FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns the creation of products based on heparin, possessing anticoagulant, antiplatelet, fibrin-depolymerization effect on the body. Complex comprises high-molecular heparin with molecular weight of 20,000 Da and aspartic acid in ratio (1±0.3) M of heparin monomer unit on (1±0.3) M of aspartic acid. Method of producing complex involves stirring of heparin and aspartic acid, where as heparin use liquid or dry high-molecular heparin in ratio (1±0.3) M of heparin per monomer unit on (1±0.3) M of aspartic acid, holding the obtained mixture at temperature of 36-37 °C for 15–20 minutes with subsequent deposition, by centrifugation and drying the deposit at room temperature.
EFFECT: group of inventions ensures the creation of agent having a more pronounced effect, increasing the range of its anticoagulant activities, improving the efficiency of the method while increasing a yield of finished product.
6 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITHROMBOTIC COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2600817C2 |
ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2454237C1 |
HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2456993C1 |
METHOD FOR MAKING ANTICOAGULANT-FIBRINOLYTIC HEPARIN PREPARATION | 2011 |
|
RU2448717C1 |
ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
ANTI-THROMBOSIS, ANTI-COAGULATING, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT | 2005 |
|
RU2290194C1 |
ANTI-THROMBOSIS, ANTI-COAGULATING, FIFRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT FOR INTRANASAL ADMINISTRATION | 2005 |
|
RU2290193C1 |
AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
Authors
Dates
2017-01-10—Published
2015-03-12—Filed